Search Results 181-190 of 17113 for monoclonal antibody
Monoclonal antibodies, such as ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-CTLA4 monoclonal antibody).
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior ...
Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, including ...
Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation. Clin Chem Lab Med. 2016 Jun 01; 54(6):1085-93. View ...
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
Of those monoclonal antibody infusions, 16,000 were administered in the Midwest, including 10,000 in rural communities throughout southern Minnesota and western ...
Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone ...
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.
That means current therapies that target the spike protein, such as monoclonal antibodies, may have reduced efficacy against the omicron variant. Exactly ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.